Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States; University of Washington Molecular and Cellular Biology Program, Seattle, United States
Sonali Arora
Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States
Ye Zheng
Division of Vaccine and infectious Diseases, Fred Hutchinson Cancer Center, Seattle, United States
Erica T Goddard
Division of Public Health Sciences, Translational Research Program, Fred Hutchinson Cancer Center, Seattle, United States
Ilsa M Coleman
Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States
Anson T Ku
Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States
Scott Wilkinson
Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States
Hanbing Song
Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, United States
Nicholas J Brady
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, United States
Robert A Amezquita
Division of Vaccine and infectious Diseases, Fred Hutchinson Cancer Center, Seattle, United States
Center for Data Visualization, Fred Hutchinson Cancer Center, Seattle, United States
Annalysa Long
Division of Public Health Sciences, Translational Research Program, Fred Hutchinson Cancer Center, Seattle, United States
Yu Chi Yang
Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States
Jason H Bielas
Division of Public Health Sciences, Translational Research Program, Fred Hutchinson Cancer Center, Seattle, United States
Raphael Gottardo
Division of Vaccine and infectious Diseases, Fred Hutchinson Cancer Center, Seattle, United States; Division of Public Health Sciences, Translational Research Program, Fred Hutchinson Cancer Center, Seattle, United States
David S Rickman
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, United States
Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, United States
Cyrus M Ghajar
Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States; Division of Public Health Sciences, Translational Research Program, Fred Hutchinson Cancer Center, Seattle, United States
Peter S Nelson
Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States; University of Washington Departments of Medicine and Genome Sciences, Seattle, United States
Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, United States
Manu Setty
Translational Data Science Integrated Research Center, Fred Hutchinson Cancer Center, Seattle, United States; Division of Basic Sciences, Fred Hutchinson Cancer Center, Seattle, United States
Division of Human Biology, Fred Hutchinson Cancer Center, Seattle, United States; University of Washington Departments of Medicine and Genome Sciences, Seattle, United States
Advanced prostate malignancies are a leading cause of cancer-related deaths in men, in large part due to our incomplete understanding of cellular drivers of disease progression. We investigate prostate cancer cell dynamics at single-cell resolution from disease onset to the development of androgen independence in an in vivo murine model. We observe an expansion of a castration-resistant intermediate luminal cell type that correlates with treatment resistance and poor prognosis in human patients. Moreover, transformed epithelial cells and associated fibroblasts create a microenvironment conducive to pro-tumorigenic immune infiltration, which is partially androgen responsive. Androgen-independent prostate cancer leads to significant diversification of intermediate luminal cell populations characterized by a range of androgen signaling activity, which is inversely correlated with proliferation and mRNA translation. Accordingly, distinct epithelial populations are exquisitely sensitive to translation inhibition, which leads to epithelial cell death, loss of pro-tumorigenic signaling, and decreased tumor heterogeneity. Our findings reveal a complex tumor environment largely dominated by castration-resistant luminal cells and immunosuppressive infiltrates.